RT @hopkinsneph: Interesting article from @NadaAlachkar and colleagues on "Monitoring suPAR levels in post-kidney transplant focal segmenta…
Interesting article from @NadaAlachkar and colleagues on "Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab" https://t.co/s344tHe370
RT @JonathanNefro: En TRASPLANTADOS con glomerulonefritis FOCAL y SEGMENTARÍA, el tratamiento con PLASMAFERESIS + RITUXIMAB disminuyen los…
RT @SunUruguay: Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchan…
RT @JonathanNefro: En TRASPLANTADOS con glomerulonefritis FOCAL y SEGMENTARÍA, el tratamiento con PLASMAFERESIS + RITUXIMAB disminuyen los…
RT @JonathanNefro: En TRASPLANTADOS con glomerulonefritis FOCAL y SEGMENTARÍA, el tratamiento con PLASMAFERESIS + RITUXIMAB disminuyen los…
RT @JonathanNefro: En TRASPLANTADOS con glomerulonefritis FOCAL y SEGMENTARÍA, el tratamiento con PLASMAFERESIS + RITUXIMAB disminuyen los…
RT @JonathanNefro: En TRASPLANTADOS con glomerulonefritis FOCAL y SEGMENTARÍA, el tratamiento con PLASMAFERESIS + RITUXIMAB disminuyen los…
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab | BMC Nephrology | Full Text https://t.co/5zr7ISzjkB
RT @JonathanNefro: En TRASPLANTADOS con glomerulonefritis FOCAL y SEGMENTARÍA, el tratamiento con PLASMAFERESIS + RITUXIMAB disminuyen los…
En TRASPLANTADOS con glomerulonefritis FOCAL y SEGMENTARÍA, el tratamiento con PLASMAFERESIS + RITUXIMAB disminuyen los niveles de suPAR lo que REDUCE la PROTEINURIA postrasplante, la única variable asociada con ese beneficio BMC Nephrology (2018) 19:361
Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab | BMC Nephrology | Full Text https://t.co/0DPPCGYFgM
RT @carlo_alfieri: Utility of suPAR levels in post-#kidney #transplant GSFS https://t.co/EdJx9tbHaO @SinReni @ASNKidney @ERAEDTA #ckd #tran…
RT @carlo_alfieri: Utility of suPAR levels in post-#kidney #transplant GSFS https://t.co/EdJx9tbHaO @SinReni @ASNKidney @ERAEDTA #ckd #tran…
Utility of suPAR levels in post-#kidney #transplant GSFS https://t.co/EdJx9tbHaO @SinReni @ASNKidney @ERAEDTA #ckd #transplantation #renal #disease #dialysis #nephrology @AST_info
Monitoring suPAR levels in post-kidney #transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab https://t.co/bfsktI3q8Y @BioMedCentral
The most convincing evidence for suPAR as the circulating factor in this specific subtype of FSGS. Have we reached the anti-PLA2RAb era for FSGS? Cheers to @JochenReiser and his team .@Nephcure https://t.co/FBU3IRitxv
suPAR level in recurrent FSGS receiving plasma exchange&rituximab is the sole predictor of therapeutic success. Prospectively and retrospectively studied by @NadaAlachkar. @HopkinsMedicine @ASNKidney @Rush_Nephrology https://t.co/xtI0TRt0sy